Business Wire

Lenovo Group: First Quarter Financial Results 2025/26

14.8.2025 01:52:00 CEST | Business Wire | Press Release

Share

Lenovo GroupLimited (HKSE: 992) (ADR: LNVGY), together with its subsidiaries (‘the Group’), today announced strong first quarter results for the fiscal year 2025/26, reporting significant growth in overall group revenue and profit. Revenue grew 22% year-on-year to US$18.8 billion, with net income up 108% year-on-year to US$505 million. On a non-Hong Kong Financial Reporting Standards (non-HKFRS[1]) basis, net income grew by 22% year-on-year to US$389 million, adjusted for non-cash fair value gain on warrants[2].

All main business groups saw solid double-digit year-on-year revenue growth, with the PC business reporting particularly strong numbers following the highest year-on-year revenue growth rate in 15 consecutive quarters and an all-time high market share of 24.6%. The Group’s diversified growth engines continue to grow, with non-PC revenue mix up nearly half a point year-on-year to 47%. All sales geographies delivered high to relatively high year-on-year revenue growth. The strong results reinforce Lenovo’s ability and commitment to preserve competitiveness, maintain market share, and sustain profitability against the challenging external environment.

Three main strategic factors drove the results. First, the Group’s firm execution of its hybrid AI vision sees it capitalizing on unprecedented AI opportunities. Second, a commitment to continuous investment in innovation, which saw R&D spending increase over 10% year-on-year, supporting the Group’s progress towards long-term goals of building personal and enterprise AI twins. And third, its operational excellence, including a unique ODM+ manufacturing model, a balanced global sales footprint, and a ‘Global/Local’ model that combines global sourcing and resources with local delivery.

The combination of these factors gives the Group maximum flexibility and resilience to navigate through market cycles and geopolitical uncertainties. Looking ahead, Lenovo remains committed to delivering more breakthrough innovations for customers, generating higher returns for its shareholders, and creating lasting value for its stakeholders and communities around the world.

Chairman and CEO quote – Yuanqing Yang:

“By leveraging the resilience and flexibility of our supply chain and operational excellence, we overcame challenges brought by tariff volatility and the geopolitical landscape and achieved significant growth in both top and bottom lines. These record Q1 results underscore our ability to deliver on our promise to preserve competitiveness and continuously grow our business. Looking ahead, we will continue to firmly execute our hybrid AI strategy towards the vision of Smarter AI for all, relentlessly drive innovation in personal AI and enterprise AI products and solutions and consistently strengthen our operational competitiveness so that we can realize sustainable growth and profitability improvement.”

Financial Highlights:

Q1 FY 25/26

US$ millions

Q1 FY 24/25

US$ millions

Change

Group Revenue

18,830

15,447

22%

Pre-tax income

622

313

99%

Net Income (profit attributable to equity holders)

505

243

108%

Net Income (profit attributable to equity holders – non-HKFRS)[1]

389

320

22%

Basic earnings per share (US cents)

4.12

1.99

107%

Lenovo management encourages investors, analysts, and the public to focus on its non-HKFRS measures, which exclude the impact of non-cash items related to warrants and convertible bonds as part of Lenovo’s strategic collaboration with Alat. Non-HKFRS offers a clearer view of the Group’s core operational performance, as the non-cash items related to warrants and notional interest on convertible bonds are expected to persist through the end of fiscal year 2027/2028.

Intelligent Devices Group (IDG): Strong growth across the board, leading in personal AI

Q1 FY25/26 performance:

  • Overall IDG revenue grew nearly 18% year-on-year to US$13.5 billion, with the PCs and smart devices business delivering 19% year-on-year revenue growth, the fastest pace in 15 quarters. All geographies achieved double-digit year-on-year revenue growth in PCs and smart devices.
  • The PCs and smart devices business maintained its industry-leading profitability with an operating profit of more than 8% thanks to a strong performance from high-margin segments.
  • PC market leadership was further reinforced with a record 24.6% market share, together with an increased lead over the number two player.
  • AI PC penetration accelerated, accounting for more than 30% of all Lenovo PC shipments. Lenovo ranks #1 globally in the Windows AI PC segment with a 31% market share.
  • Smartphone revenue grew over 14% year-on-year to US$2.2 billion, with sales volume outgrowing the market for eight consecutive quarters. In markets outside of China, smartphone market share reached a record high, with the success of the Razr phone seeing Motorola take the #1 position in foldables (flip and fold) with over 50% market share.
  • Looking ahead, IDG will continue to build agent-native devices of various forms, while enriching the application ecosystem for AI super agent to boost agent user engagement. This will drive toward “One AI, Multiple Devices”, positioning agent-native devices as the entry point for Personal AI.

Infrastructure Solutions Group (ISG): Sustained high growth, building long-term competitiveness

Q1 FY25/26 performance:

  • ISG delivered strong revenue growth of up 36% year-on-year to US$4.3 billion through a strong execution of its CSP (Cloud Service Provider) and E/SMB (Enterprise and SMB) dual strategy.
  • Increasing investments in AI infrastructure and R&D, as well as enhancing E/SMB competitiveness, even as profitability was impacted in the short-term.
  • The AI infrastructure business revenue more than doubled year-on-year with a robust pipeline and a clear product roadmap ahead. Revenue from industry-leading liquid cooling solutions grew 30% year-on-year.
  • Looking ahead, ISG is committed to investing in driving long-term growth and value through strategic market expansion, E/SMB business model transformation, AI infrastructure innovation and product development, to stay ahead of the AI curve and provide differentiated global competitiveness. The Group is confident that ISG will not only sustain mid-to-long-term growth, but also deliver stronger profitability returns.

Solutions and Services Group (SSG): High growth and high profitability, unleashing Lenovo hybrid AI Advantage

Q1 FY25/26 performance:

  • SSG delivered another record quarter of revenue, up 20% year-on-year to US$2.3 billion – marking 17 consecutive quarters of year-on-year revenue growth.
  • Operating margin was up 1.2 points year-on-year to over 22% - making SSG the key profit engine for the Group overall, thanks to its sustainable margin expansion.
  • Support Services achieved double-digit year-on-year revenue growth by leveraging strong market demand for hardware and focusing on attaching premium services, e.g., Premium Care and Premier Support Plus.
  • Managed services, and “as-a-Service” offerings, along with Projects and Solutions grew even faster with TruScale Infrastructure-as-a-service delivering triple-digit growth year-on-year in signings, and TruScale Device-as-a-service seeing double-digit growth for the quarter. Their combined mix increasing three points year-on-year to 58% of SSG’s total revenue.
  • AI-driven solutions have gained momentum, especially in manufacturing and supply chain sectors.
  • Looking ahead, Lenovo will further build the Lenovo Hybrid AI Advantage framework as its key differentiator and will focus on Digital Workplace Solutions, Hybrid Cloud, and Sustainability solutions, while at the same time building simple and scalable AI-led vertical solutions to solve customers’ most significant needs.

Corporate and ESG highlights

Lenovo published its FY2024/25 Environmental, Social and Governance Report in June 2025, key highlights included:

  • Detailed progress towards the Group’s 2030 emissions reduction targets, including reaffirming its long-term ambition to achieve net-zero greenhouse gas emissions by 2050.
  • Environmental progress through participation in the circular economy, including the continuous use of closed-loop recycled materials in its products as well as sustainability services for customers.
  • The Group’s sustainability performance was recognized by 3rd parties such as EcoVadis (Platinum Medal), MSCI ESG Ratings (AAA), and CDP (A list in climate, water security and supplier engagement). The Group’s governance and reporting was additionally recognized with a Gold Award from the Hong Kong Institute of Certified Public Accountants (HKICPA) for Best Corporate Governance and ESG.

Lenovo was recently ranked #8 in Gartner’s Top 25 Global Supply Chain, with an ESG Score of 9/10. The ranking recognizes excellence in supply chain operations among global leaders across various industries, including pharmaceutical, automotive, FMCG, and technology. The prestigious Gartner ranking highlights companies that consistently demonstrate leadership in supply chain strategy and execution.

In July 2025 Lenovo climbed 52 spots on the Fortune Global 500 list. This achievement marks Lenovo’s 16th year on the Global 500, highlighting it as one of the world’s 500 largest companies by revenue, with its highest ranking in the Technology sector to date – placing 13th among the global technology industry.

[1] Non-HKFRS measure was adjusted by excluding net fair value changes on financial assets at fair value through profit or loss, amortization of intangible assets resulting from mergers and acquisitions, gain on deemed disposal of a subsidiary, impairment and write-off of intangible assets, property, plant and equipment and construction-in-progress, fair value change on derivative financial liabilities relating to warrants, and notional interest of convertible bonds; and the corresponding income tax effects, if any.

[2] Effects of warrant obligations will fluctuate positively or negatively in the coming quarters (through the end of FY27/28), primarily based on share price movements in the quarter. Lenovo encourages the market to focus on its underlying operational performance as reflected by non-HKFRS reporting.

About Lenovo

Lenovo is a US$69 billion revenue global technology powerhouse, ranked #196 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.

LENOVO GROUP

FINANCIAL SUMMARY

For the quarter ended June 30, 2025

(in US$ millions, except per share data)

Q1
FY25/26

Q1
FY24/25

Y/Y CHG

Revenue

18,830

15,447

22%

Gross profit

2,774

2,560

8%

Gross profit margin

14.7 %

16.6%

(1.9) pts

Operating expenses

(1,989)

(2,066)

(4)%

R&D expenses
(included in operating expenses)

(524)

(476)

10%

Expenses-to-revenue ratio

10.6%

13.4%

(2.8) pts

Operating profit

785

494

59%

Other non-operating income/(expenses) – net

(163)

(181)

(10)%

Pre-tax income

622

313

99%

Taxation

(84)

(60)

42%

Profit for the period

538

253

112%

Non-controlling interests

(33)

(10)

218%

Profit attributable to equity holders

505

243

108%

Profit attributable to equity holders – non-HKFRS[1]

389

320

22%

Earnings per share (US cents)
Basic
Diluted

4.12

3.65

1.99

1.92

2.13

1.73

View source version on businesswire.com: https://www.businesswire.com/news/home/20250813743723/en/

Contacts

Press Contacts
Hong Kong – Angela Lee,angelalee@lenovo.com
London – Charlotte West, cwest@lenovo.com
Zeno Group - LenovoWWcorp@zenogroup.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press Release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye